Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712638 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Undiagnosed Sleep Disorder Market Offers Growth Opportunities

Koncept Analytics, April 2008, Pages: 31


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

There are more than 70 different sleep disorders but the most common ones include insomnia, sleep apnea, restless legs syndrome, and narcolepsy. One of the fastest growing sector in the sleep disorder treatment market is obstructive sleep apnea (OSA) products. OSA affects up to 18 million patients in the US with as many as 85% are undiagnosed.

Similarly, 30 million are chronic sufferers of insomnia but only a third of chronic sufferers are receiving treatment. A key reason for this low percentage of people receiving treatment is the side effects associated with most of the insomnia drugs. Over 1.6 million Americans use some form of alternative medicine to treat insomnia.

With rising awareness of sleep disorders, more people are undergoing tests to understand the basics of their sleep disorder condition. Hospitals are opening new sleep centres and upgrading old ones. Patients are looking at innovative aspects in sleep centres which make them feel more homely.

Pharma companies are coming up with new sleeping disorder drugs. Gamma Aminobutyric Acid (GABA) agents dominate the insomnia market. More than a dozen insomnia drugs are in phase II and phase III clinical trials. Major products are Ambien, Ambien CR, Lunesta, Temazepam, and Zolpidem. Respironics and ResMed are the leading competitors in the continuous positive airway pressure (CPAP) market.

The report analyzes the sleep disorder treatment market. The focus is on OSA and insomnia treatment products. The report also profiles the major companies, with a discussion of their key business strategies. It also analyzes the major market and demographic trends prevalent in the sleep disorder treatment market.



Customers who bought this item also bought

Sleep Apnea Diagnostic And Therapeutic Devices - Global Strategic Business Report

The Global Market For Sleep-Wake Disorders, 2005-2012: Trends, Opportunities, and Insights in A High-Value CNS Therapy Area

Respiratory Care Equipment And Supplies - Global Strategic Business Report

Medical Devices Bundle

Apnea Monitors - A Global Market Perspective

Sleep Apnea Diagnostic and Therapeutic Devices - Worldwide Market Challenges & Opportunities

Sleep Disorders: Promotion and Awareness Will Drive Market Growth

Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond

Sleep Apnea Diagnostic & Therapeutic Devices Worldwide

Sleep Apnea Diagnostic Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds